R&D channel feed – Endpoints News

R&D channel feed

J&J trims pipeline, including two mid-stage neuroscience studies

7 months ago

MeiraGTx's stock rises on small Parkinson's gene therapy dataset

7 months ago

Pfizer partners with molecular glue startup Triana in $49M upfront deal

7 months ago

Maryland biotech gets green light for stem cell-derived therapy for diabetes, aiming to compete with Vertex

7 months ago

Two GSK trials with long-acting drug in chronic rhinosinusitis hit primary endpoints

7 months ago

Pfizer details results from failed Phase 3 trial of Duchenne muscular dystrophy gene therapy

7 months ago

Jasper shares rally as chronic hives drug scores in small, early trial

7 months ago

Novartis ends mid-stage IPF trial, will keep testing drug in PAH

7 months ago

Exclusive: British startup raises $16M to find genes that rewind the epigenetic clock

7 months ago

Transgene shares dip as therapeutic cancer vaccine disappoints in Phase 2 trial

7 months ago

Pfizer gets an FDA win in hemophilia after a rough week

7 months ago

Perspective’s early data on lead-based radiopharma asset suggest lower dose did better

7 months ago

Turnstone rejigs staff and exec team, eases preclinical work as cash runs low

7 months ago

Sanofi discontinues Denali-partnered MS trial after Phase 2 failure

7 months ago

Seven patients diagnosed with blood cancer after Skysona treatment, new data show

7 months ago

Immatics heads to Phase 3 with melanoma cell therapy, seeks to raise $150M

7 months ago

Starboard launches first salvo in Pfizer fight, alleging ex-CEO, CFO were pressured to flip

7 months ago

Gritstone files for bankruptcy, says it could forge a transaction as early as this month to keep R&D going

7 months ago

‘Just the beginning’: Nobel Prizes show the AI era has arrived in biotech

7 months ago

Clearside shares jump as reformulated TKI drug passes mid-stage test in wet AMD

7 months ago

David Baker, Demis Hassabis and John Jumper win chemistry Nobel for computational protein prediction and design

7 months ago

AI biotech insitro partners with Lilly on metabolic disease drugs

7 months ago

GSK's RSV vaccine Arexvy shows long-term protection in Phase 3 trial

7 months ago

Pfizer culls RSV treatment from ReViral acquisition

7 months ago

First page Previous page 21 22 232425 26 27 Next page Last page